Ionis Pharmaceuticals (IONS) PT Raised to $50 at Stifel; Reiterates Hold

August 9, 2017 7:08 AM

Stifel raised its price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $50.00 (from $42.00) while maintaining a Hold rating following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found